APA (7th ed.) Citation

Marina, M., Maggie, C., Lakov, B., Thomas, N., Adam, J., Tanya, A., . . . Sarah, B. (2025). 92 Clinical impact and real-world UK multi-center experience of neoadjuvant chemoimmunotherapy for resectable NSCLC. Lung Cancer (01695002), 200, N.PAG. https://doi.org/10.1016/j.lungcan.2025.108202

Chicago Style (17th ed.) Citation

Marina, Milic, et al. "92 Clinical Impact and Real-world UK Multi-center Experience of Neoadjuvant Chemoimmunotherapy for Resectable NSCLC." Lung Cancer (01695002) 200 (2025): N.PAG. https://doi.org/10.1016/j.lungcan.2025.108202.

MLA (9th ed.) Citation

Marina, Milic, et al. "92 Clinical Impact and Real-world UK Multi-center Experience of Neoadjuvant Chemoimmunotherapy for Resectable NSCLC." Lung Cancer (01695002), vol. 200, 2025, p. N.PAG, https://doi.org/10.1016/j.lungcan.2025.108202.